Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Apollon logo — The wearable that reads your glucose

Apollon

The wearable that reads your glucose

Founded 2021 Korea South Korea South 40 employees Seed Total: $2.30B Biotechnology, Health Care +3

General Information

Company Name Apollon
Founded Year 2021
Location Korea South Korea South
Founders / Decision Makers
Team member
Employees 40
Industries Biotechnology, Health Care, Medical Devices +2
Funding Stage Seed
Business Model B2C, D2C, SaaS
Revenue Model Product Sales, Subscription, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with Apollon. To contact Apollon, visit apollon.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Apollon compare?

A PDF of Apollon and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Apollon soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

AI Insight

Bounce Watch AI
1 month ago

Apollon is strategically fortifying its clinical expertise with the appointment of Dr. Medha Munshi to its Advisory Board, a critical move for guiding clinical strategy and evidence generation as they progress through trials. This significant team strengthening, coupled with their active solicitation of fundraising advice, strongly indicates the company is preparing for an upcoming capital raise to support its continued development and validation efforts.

Signal Types
Hiring Funding
Strategic Labels
Clinical Strategy Team Strengthening Fundraising Preparation
Next Move: Fundraising
·
Impact: 8/10
·
Ideal For: Early-stage MedTech & Deep Tech VCs – Series A

About Apollon

Apollon, founded in 2021, is revolutionizing diabetes management with Moglu, a pioneering wearable that continuously reads glucose through the skin without needles, patches, or consumables. This innovative device leverages Raman spectroscopy, developed alongside MIT, and is currently undergoing clinical trials at a Harvard-affiliated hospital. Based in both Boston and Seoul, the company is positioned at the intersection of Biotechnology, Health Care, Medical Devices, and cutting-edge Sensor Tech and Machine Learning.

Apollon’s headquarters in South Korea provides strategic access to key markets in Asia and beyond. The company's recent Seed investment of KRW2.30B, closed on April 1, 2024, saw participation from prominent investors including KB Investments, BeHigh Investment, STIC Ventures, and Mirae Science and Technology. This funding underscores strong market confidence in Apollon's potential to transform diabetes care.

Taxonomy: wearable technology, glucose monitoring, diabetes management, non-invasive medical devices, Raman spectroscopy, medical technology innovation, biomedical engineering, clinical trials, MIT collaboration, Harvard-affiliated research, medical device startup, continuous monitoring technology

Services & Products

Development of needle-free continuous glucose monitors
Research and innovation in Raman-based glucose sensing
Integration of optical engineering in wearable medical devices

Target Customers

Individuals with diabetes Healthcare professionals Medical institutions Patients seeking non-invasive monitoring solutions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed KRW2.30B 4
KB Investments BeHigh Investment
KB Investments, BeHigh Investment +2
01 Apr 2024
Seed Undisclosed 1
TheVentures Co., Ltd.
TheVentures Co., Ltd.
01 Aug 2023

Apollon Alternatives & Competitors

View All Alternatives
Apollon vs
GraphWear Technologies Inc.
GraphWear Technologies Inc. United States

#notblood

Series B
6 employees
Health Care, Medical Devices
Apollon vs
SiBionics
SiBionics China

Technology Empowering Healthcare

Series D
47 employees
AI, Health Care
Apollon vs
Endogenex
Endogenex United States

Treating the gut may redefine what's possible in diabetes care.

Series C
27 employees
Health Care, Health and Wellness
Also compare with: Apollon vs Echo Therapeutics Echo Therapeutics View all alternatives

FAQ About Apollon

The wearable that reads your glucose
Apollon was founded in 2021.
Apollon is headquartered in Korea South.
Apollon operates in Biotechnology, Health Care, Medical Devices, Autonomous and Sensor Tech and Machine Learning. Its work centres on wearable technology, glucose monitoring, diabetes management and non-invasive medical devices. Its customers include Individuals with diabetes, Healthcare professionals and Medical institutions.
Apollon has a B2C, D2C and SaaS business model. Its revenue comes from Product Sales, Subscription and Tiered Pricing.
Apollon has approximately 40 employees.
Apollon has completed 2 funding rounds, raising a total of $2.30B. The latest funding stage is Seed.
Apollon offers: Development of needle-free continuous glucose monitors, Research and innovation in Raman-based glucose sensing, Integration of optical engineering in wearable medical devices.
Top alternatives and competitors to Apollon include GraphWear Technologies Inc., SiBionics, Endogenex, RSP Systems, Echo Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Apollon and GraphWear Technologies Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Apollon, https://bouncewatch.com/company/apollon, updated 6 August 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes